Highly sensitive and specific bioassay for measuring bioactive TGF-β by Tesseur, Ina et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Cell Biology
Open Access Methodology article
Highly sensitive and specific bioassay for measuring bioactive TGF-β
Ina Tesseur1, Kun Zou1,3, Elisabeth Berber1, Hui Zhang1 and Tony Wyss-
Coray*1,2
Address: 1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA, 2GRECC, VA 
Palo Alto Health Care System, Palo Alto, CA 94304, USA and 3Department of Alzheimer's Disease Research, National Center for Geriatrics and 
Gerontology, Obu, Aichi 474-8522, Japan
Email: Ina Tesseur - itesseur@stanford.edu; Kun Zou - kunzou@nils.go.jp; Elisabeth Berber - eberber@stanford.edu; 
Hui Zhang - huizhang@stanford.edu; Tony Wyss-Coray* - twc@stanford.edu
* Corresponding author    
Abstract
Background: Transforming Growth Factor-β (TGF-β) regulates key biological processes during
development and in adult tissues and has been implicated in many diseases. To study the biological
functions of TGF-β, sensitive, specific, and convenient bioassays are necessary. Here we describe
a new cell-based bioassay that fulfills these requirements.
Results: Embryonic fibroblasts from Tgfb1-/- mice were stably transfected with a reporter plasmid
consisting of TGF-β responsive Smad-binding elements coupled to a secreted alkaline phosphatase
reporter gene (SBE-SEAP). Clone MFB-F11 showed more than 1000-fold induction after
stimulation with 1 ng/ml TGF-β1, and detected as little as 1 pg/ml TGF-β1. MFB-F11 cells were
highly induced by TGF-β1, TGF-β2 and TGF-β3, but did not show induction with related family
members activin, nodal, BMP-2 and BMP-6 or with trophic factors bFGF and BDNF. MFB-F11 cells
can detect and quantify TGF-β in biological samples without prior enrichment of TGF-βs, and can
detect biologically activated TGF-β in a cell co-culture system.
Conclusion: MFB-F11 cells can be used to rapidly and specifically measure TGF-β with high
sensitivity.
Background
Transforming growth factor-β (TGF-β) is the prototype
member of a superfamily of growth factors that includes
activins, bone morphogenic proteins (BMPs), inhibins,
growth and differentiation factors (GDFs), and glial
derived neurotrophic factor (GDNF) [1]. TGF-β is widely
distributed in both embryonic and adult tissues and regu-
lates cell proliferation and differentiation, extracellular
matrix production, wound healing, immune function,
apoptosis, angiogenesis, chemotaxis and hematopoiesis.
Many human diseases, including certain forms of cancer
as well as fibrotic and inflammatory disorders, have alter-
ations in the TGF-β signaling pathway (reviewed in [2,3]).
Recently, TGF-β has also been implicated in Alzheimer's
Disease and other neurodegenerative conditions [4,5].
In mammals, TGF-β has three closely related isoforms,
TGF-β1, -2 and -3, which share 70% sequence identity but
exhibit different functions in vivo (reviewed in [1]). The
biological functions of TGF-β are mediated through a
high-affinity transmembrane receptor complex consisting
of TGF-β type I (ALK5) and type II serine/threonine kinase
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receptor subunits (reviewed in [1,6,7]). Upon binding of
the ligand, ALK5 recruits and phosphorylates receptor-
regulated Smad2 or Smad3, which then form heteromeric
complexes with Smad4 and translocate into the nucleus,
where together with other transcription factors they regu-
late gene transcription [6]. Smad3 binds directly to DNA
via a conserved Smad-binding element (SBE) that consists
of one or more CAGA boxes [8]. This CAGA box is present
in an estimated 500 target genes for TGF-β in mammals
[6,9]. Smad2 normally does not bind to DNA, although
an alternatively spliced form of Smad2, which lacks exon
3, can bind with high affinity to SBE and appears to be
present in many cell types [10]. Activins, nodal, growth
and differentiation factor (GDF)-8/myostatin, GDF-9,
and GDF-11 also signal via Smad2/3 proteins by engaging
activin receptors or ALK5 [6,11-14]. In contrast, BMPs
recruit Smad1, Smad5, and Smad8 in combination with
Smad4 after binding to BMP type I and type II receptors
[6,7]. In addition, signaling of TGF-β s and related factors
is regulated by crosstalk with other signaling pathways
including MAP kinase, JAK/STAT, and Wnt pathways
(reviewed in[15]).
TGF-β is secreted as a latent pro-peptide, and does not sig-
nal unless activated. Activation in vivo is still poorly under-
stood and can involve integrins, thrombospondin,
metalloproteases, plasmin, furin and other proteases
[16,17]. Bioactive TGF-β peptides are rapidly inactivated
in living cells and consequently, bioactive TGF-β peptides
are usually not detectable in tissues, body fluids, or super-
natants from cultured cells. However, latent TGF-β in such
samples can be "activated" with acids, heat, or other
methods [18]. To measure levels of bioactive TGF-β in
activated samples, several assays including wound healing
and growth inhibition assays or reporter gene assays have
been developed [18-21], but many of these assays are
cumbersome and complicated or can be influenced by
other growth factors present in the samples. Currently one
of the most frequently used bioassays is based on a mink
lung cell line (TMLC) stably transfected with a plasmino-
gen activator inhibitor-1 (PAI-1) promoter fused to luci-
ferase [19]. TMLC cells have also been used in coculture
with other cells to measure their TGF-β production
[22,23]. In this paradigm, TMLC cells seem to measure
TGF-β activated via integrins [22]. A disadvantage of the
TMLC cells however, is that they can be induced by other
growth factors present in the samples [19,21].
Here we describe a new bioassay that is specific for TGF-
βs, is sensitive and reproducible and allows for repeated
measurements of the same sample in induced reporter
cells. We stably transfected mouse embryonic fibroblasts
from Tgfb1-/- mice with a synthetic promoter element con-
taining twelve CAGA boxes [8], fused to a secreted alka-
line phosphatase (SEAP) reporter gene. Clone MFB-F11
showed up to 1000 fold induction with 1 ng/ml TGF-β1
(40 pM) and showed a linear response to TGF-β1 from 1
pg/ml to 10 ng/ml. TGF-β1, TGF-β2 and TGF-β3 but not
other related TGF-β family members activated the reporter
gene in these cells. We demonstrate that this new cell line
can be used to quantitatively measure TGF-β bioactivity
from body fluids, tissues and cell culture supernatants.
Importantly, MFB-F11 cells can detect TGF-β bioactivity
directly from other cells in co-culture systems.
Results
Generation of SBE-SEAP reporter cells to measure TGF-β 
signaling
To measure TGF-β bioactivity from cell culture superna-
tants or biological fluids rapidly, specifically, and with
high sensitivity we developed a new cell-based reporter
assay. We used a fibroblast cell line isolated from mouse
Tgfb1-/- embryos (MFB), which showed low background
and high induction of the SBE-SEAP reporter during tran-
sient transfections. The SBE-SEAP reporter plasmid was
generated from a previously described SBE-luciferase plas-
mid [8] by replacing firefly luciferase with SEAP. The SEAP
protein is secreted into the medium, and allows multiple
measurements from the same culture.
MFB cells were stably transfected with SBE-SEAP and a
total of 49 stably-transfected colonies were examined for
induction of reporter activity by TGF-β1. Out of 7 clones
with strong induction, clone MFB-F11 showed the highest
and most consistent activity with relatively low back-
ground levels (Figure 1A). Clones that showed induction
at passage 2 were retested after 9–12 passages (Figure 1B).
Clone MFB-F11 was not only the most inducible but also
Selection of MBF-F11 cells Figure 1
Selection of MBF-F11 cells. Tgf-b1-/- mouse embryonic fibrob-
last clones that are stably transfected with SBE-SEAP (Clones 
1 – 42) show induction of the reporter after treatment with 
1 ng/ml TGF-β1 at passage 2 (A) and at passage 9–12 (B). 
Clone 43 is a control non-inducible clone. Assays were per-
formed in 1 ml total volume and SEAP activity was measured 
in 10 µl supernatant after 24 h induction. The baseline meas-
urement (no TGF-β) of each clone was used to calculate fold 
induction.BMC Cell Biology 2006, 7:15 http://www.biomedcentral.com/1471-2121/7/15
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the most stable clone, and was still inducible without sig-
nificant loss of sensitivity after more than 30 passages
(data not shown).
MFB-F11 cells can measure as low as 1 pg/ml TGF-β1
To further characterize MFB-F11 cells, we assayed induc-
tion of reporter activity using a broad range of TGF-β1
concentrations at different cell densities. Higher cell den-
sities showed a better induction with TGF-β1 concentra-
tions in the ng/ml range (Figure 2A), whereas 30,000
cells/well in a 96-well tissue culture plate seemed to work
best with TGF-β1 concentrations between 1 and 100 pg/
ml (Figure 2B). At 30,000 cells/well MFB-F11 showed a
significant 2-fold induction with only 1 pg/ml TGF-β1 in
the presence of B27 supplement, which provides the cells
with additional nutrients when cultured in serum free
medium (Figure 2C, P < 0.05 unpaired Student's t test),
and the response was linear up to 1 ng/ml TGF-β1. At this
concentration the reporter was induced more than 1000
fold (Figure 2C). Higher cell densities did not further
increase induction and usually resulted in lower induc-
tion (data not shown). TMLC cells, which have been
widely used to measure TGF-β activity in cell culture,
showed a similar dose-dependent response to TGF-β1. In
our hands however, the maximal fold induction was
higher in MFB-F11 cells (Figure 2A and 2D).
MFB-F11 cells specifically measure TGF-β1, TGF-β2 and 
TGF-β3
To examine whether MFB-F11 cells would also respond to
growth factors other than TGF-β1, we tested induction of
SEAP activity with TGF-β2, TGF-β3, nodal, activin B,
BMP2, BMP6, GDNF and bFGF. The closely related TGF-
β1 family members TGF-β2 and TGF-β3 induced SEAP
activity in MFB-F11 cells in a dose-dependent manner
(Figure 3A). In contrast, nodal, activin B, BMP2, BMP6,
BDNF and bFGF did not induce SEAP acitivity, even at
high concentrations (Figure 3B) or after 48 or 96 h induc-
tion (data not shown). The latter also did not induce SEAP
reporter activity when added together with different
amounts of recombinant TGF-β1, TGF-β2 or TGF-β3 (data
not shown). Taken together these results suggest that
MFB-F11 cells respond specifically to TGF-βs.
MFB-F11cells measure TGF-βs from biological samples
To determine the use of MFB-F11 cells in measuring TGF-
β from biological samples, we tested mouse serum, mouse
brain extract and conditioned medium from McA-
7777RH liver cells (Figure 4A–C) or Chinese hamster
ovary (CHO) cells (data not shown). After activation of
presumably latent TGF-β with acid all samples were able
to strongly induce reporter activity in MFB-F11 cells (Fig-
ure 4A–C). Co-incubation of activated samples with a
TGF-β neutralizing antibody nearly completely inhibited
induction (Figure 4A–C), demonstrating that MFB-F11
cells specifically measure TGF-β activity in biological sam-
ples. Samples that were not activated with acid did not
induce reporter activity (Figure 4A and 4B) consistent
with the presence of TGF-β in a latent form in biological
samples [16].
To determine the use of MFB-F11 cells in measuring bio-
logically activated TGF-β, we co-cultured them with other
cell types. Co-culture with McA-7777RH cells (Figure 4D)
or B103 cells (data not shown) resulted in significant
induction of SEAP activity. The relative activity detected in
TGF-β1 dose-dependently induces SEAP reporter activity in  MFB-F11 cells Figure 2
TGF-β1 dose-dependently induces SEAP reporter activity in 
MFB-F11 cells. A, B: MFB-F11 cells were cultured at different 
cell densities with the indicated concentrations of TGF-β1 
and SEAP activity was measured in the supernatant. (B) 
shows a higher magnification of the x-axis shown in (A) in the 
lower range of TGF-β1. C: 3 × 104 MFB-F11 cells/well were 
incubated with the indicated concentrations of TGF-β1 in 
B27 supplemented, serum-free DMEM. Note the logarithmic 
scale. Bars represent mean ± SEM of triplicate wells from 
one representative experiment. D: 4 × 104 TMLC cells/well 
were incubated with the indicated concentrations of TGF-β1 
in serum-free DMEM. All assays were performed in 100 µl 
total volume in 96-well tissue culture plates and SEAP or luci-
ferase activity was measured after 24 h induction in 10 µl 
supernatant or 50 µl cell pellet respectively. * P < 0.05; ** P < 
0.001, Student's t test compared to 0 pg/ml TGF-β1 in C.BMC Cell Biology 2006, 7:15 http://www.biomedcentral.com/1471-2121/7/15
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this co-culture system was lower than what was measured
in acid activated conditioned medium of the same cells
(Figure 4B), suggesting that part of the secreted TGF-β is in
a latent form and cannot be detected by MFB-F11 cells.
Taken together these data demonstrate that MFB-F11 cells
can be used to specifically measure TGF-β1, TGF-β2 and
TGF-β3 activities with high sensitivity in biological sam-
ples.
Discussion
In this study we describe the generation of a stably trans-
fected Tgf-b1-/- fibroblast cell line (clone MFB-F11), which
provides a specific, sensitive, reproducible and convenient
bioassay for the quantification of TGF-βs in biological
samples from different species.
The major advantages of the presented method over pre-
vious TGF-β bioassays are the high sensitivity and specifi-
city of MFB-F11 cells for TGF-βs. MFB-F11 cells can
reliably measure as little as 1 pg/ml TGF-β1 and their lin-
ear range extends well beyond 1000 pg/ml (Figure 2),
whereas a typical TGF-β1 ELISA measures between 32–
1000 pg/ml TGF-β1 [24]. Although the MFB-F11 assay
and TMLC luciferase assay measure TGF-β1 with the same
sensitivity at the lower end [19], the fold induction of the
MFB-F11 assay compare favorably to the TMLC luciferase
assay. This increased dynamic range and higher fold
induction could be the result of an increased stability or
accumulation of the SEAP protein in the medium.
Another disadvantage of the luciferase assay is that it
requires lysis and harvesting of cells, whereas the SEAP
assay only requires 10 µl of cell culture medium to meas-
ure induction. As removal of a small part of cell culture
medium is non invasive, it also allows sequential meas-
urements of induction in the same cells. In addition, the
cell pellet can be used to measure other biochemical
parameters.
The second advantage of our assay is the specificity of
MFB-F11 cells for TGF-βs. Smad proteins play a key role in
the intracellular signaling of TGF-βs and its closely related
family members. Smad2 and Smad3 transduce signals
from TGF-βs, activins, nodal, inhibins and GDF1 to the
nucleus, whereas Smad1 and Smad5 are the intracellular
signaling components of BMPs and GDF5 signaling
(reviewed in [1,6]). Smad3 and Smad4, but not Smad1 or
Smad2 were shown to bind to SBE [8], which was used to
generate the SBE-SEAP reporter construct present in the
MFB-F11 cells. Interestingly, both nodal and activin do
not activate the reporter in the MFB-F11 cells (Figure 2).
This is in contrast with signaling in SBE-luciferase primary
astrocytes, where both activin and nodal were able to
induce luciferase reporter activity [25], and in TMLC cells,
where other growth factors were able to induce reporter
activity, either alone or in combination with TGF-βs
[19,21]. It is possible that MFB-F11 cells lack some of the
receptors necessary for activin and nodal signaling. The
differences in specificity between the TMLC and MFB-F11
cells could also be due to differences in promoter ele-
ments preceding the reporter gene. MFB-F11 cells contain
a minimal 12-repeat CAGA box, which has been described
to only respond to Smad-mediated signaling [8], whereas
the TMLC cells contain a PAI-1 promoter element, which
is able to bind additional transcription factors [26]. In any
case, both the absence of reporter induction by TGF-β
related factors (Figure 2), as well as by biological samples
treated with pan-specific TGF-β neutralizing antibodies
(Figure 3), demonstrates the high specificity of MFB-F11
cells for TGF-βs. In addition the MFB-F11 bioassay is valid
across species and can measure TGF-βs from human
(recombinant human TGF-β1, 2 or 3 and TGF-βs present
in human serum), mouse, rat (Figure 2, Figure 4) and
hamster (data not shown).
MFB-F11 cells are specific for TGF-βs Figure 3
MFB-F11 cells are specific for TGF-βs. A: MFB-F11 cells (4 × 
104/well) were stimulated with the indicated concentrations 
of TGF-β1, 2 and 3. Note the logarithmic scale. B: MFB-F11 
cells (4 × 104/well) were stimulated with 0.1 ng (TGF-β1, 2, 
3) or 10 ng (activin B, nodal, BMP2, BMP6, BDNF, bFGF) of 
growth factors. SEAP activity was measured after 24 h as 
described in Figure 2. Bars represent mean ± SEM of tripli-
cate wells from 1 representative experiment. ** P < 0.001, 
Student's t test compared to control.BMC Cell Biology 2006, 7:15 http://www.biomedcentral.com/1471-2121/7/15
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The third advantage of our assay is that it can measure bio-
logically active TGF-β secreted by cells (Figure 4D). Most
cells secrete TGF-βs as inactive complexes, although
freshly isolated LPS-stimulated murine peritoneal macro-
phages were able to activate TGF-βs [27]. In TMLC cells,
co-culture with a different cell type resulted in activation
of the reporter when β 6-integrin was overexpressed in the
co-cultured cell line [22,23]. In contrast, MFB-F11 cells
were able to detect TGF-β activity from two different co-
cultured cell lines without further manipulations. It is
important to note that induction of SEAP-activity via co-
culture was lower than induction via acid-activation of
conditioned medium from the same cells (Figure 4B and
4D), indicating that MFB-F11 cells were able to detect
only a portion of secreted TGF-βs. The fact that we did not
observe SEAP induction in non-acid treated conditioned
medium, but only in co-culture suggests that cell-cell con-
tact or close proximity is required for biological activation
of secreted TGF-βs. Biologically active TGF-β could be
associated with the cell membrane [28-30] or secreted in
such low amounts that it needs to be secreted immedi-
ately adjacent to the reporter cell to be detectable and
secretion into conditioned medium could dilute or inacti-
vate TGF-βs.
Conclusion
We generated a new bioassay that can measure physiolog-
ical amounts of TGF-β present in biological samples in a
highly sensitive, specific, reproducible, and convenient
way without the need for prior enrichment of TGF-βs in
the samples. Besides quantifying TGF-β this bioassay can
also be used to study TGF-β signaling and to rapidly iden-
tify new endogenous or pharmaceutical modifiers of the
TGF-β signaling pathway in the absence of TGF-β1.
Methods
Cloning of reporter plasmid
A TGF-β responsive NheI/HindIII fragment, containing 12
repeats of the (CAGA) box and a herpes simplex virus thy-
midine kinase minimal promoter (TK) promoter was iso-
lated from a SBE12-luciferase reporter gene ([8], kindly
obtained from Dr. D. Vivien, University of Caen, France).
This fragment was then ligated into the NheI/HindIII site
of the pSEAP2-Basic plasmid (BD Biosciences, San Jose,
CA). The final structure of the SBE-SEAP reporter plasmid
was confirmed by sequencing.
Cell lines and generation of reporter cells
Transformed Mink Lung Cells (TMLC) stably transfected
with a PAI-1-luciferase reporter gene (obtained from Dr.
D. Rifkin; New York University, NY) and McA-RH7777 rat
hepatoma cells (ATCC CRL 1601, Manasses, USA) were
cultured in DMEM medium supplemented with penicil-
lin/streptomycin and 10% fetal bovine serum (GIBCO,
Carlsbad, CA). To generate TGF-β reporter cells, mouse
fibroblasts isolated from Tgfb1-/- mice (MFB) were stably
transfected with the SBE-SEAP plasmid. Briefly, MFB cells
were seeded at 105 cells/well in 6-well plates and trans-
fected 16 h later with 2 µg SBE-SEAP, and 0.2 µg hygromy-
cin resistance plasmid (Promega, Madison, WI) using
Lipofectamine Plus (Invitrogen, Carlsbad, CA), according
to manufacturer's instructions. Two days later, cells were
reseeded at different densities and selected for antibiotic
resistance using 100 µg/ml hygromycin B (Invitrogen,
Carlsbad, CA). Individual colonies were isolated,
expanded, and tested in reporter cell assays.
Reagents and samples for bioassays
Transforming Growth Factor-β1 (TGF-β1), TGF-β2, TGF-
β3, activin B, BMP2, BMP6 and nodal were all purchased
from R&D Systems (Minneapolis, MN), basic FGF (bFGF)
was from PeproTech, Inc (Rocky Hill, NJ), and GDNF was
from Upstate (Charlottesville, VA). All factors were
recombinant human proteins. A TGF-β antibody (1D11)
MFB-F11 cells can measure biologically active TGF-β and  TGF-βs from various sources and species Figure 4
MFB-F11 cells can measure biologically active TGF-β and 
TGF-βs from various sources and species. MFB-F11 cells (4 × 
104 cells/well) were incubated with 100 µl diluted (1: 100) 
mouse serum (A), McA-7777RH cell culture supernatant (B) 
or diluted (1:50) mouse brain extract (C) which were either 
not activated (NA) or activated with acid (AA). Activated 
medium was incubated with a pan-specific TGF-β neutralizing 
antibody (AA + 1D11) or left untreated (AA). D: 4 × 104 
MFB-F11 cells/well were left untreated or co-cultured with 4 
× 104 McA-7777RH cells/well. SEAP activity was measured 
after 24 h as described in Figure 2. Bars represent mean ± 
SEM of triplicate wells from 1 representative experiment. 
Note the logarithmic scale in A and C.BMC Cell Biology 2006, 7:15 http://www.biomedcentral.com/1471-2121/7/15
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neutralizing all three TGF-β isoforms was purchased from
R&D systems (Minneapolis, MN). Mouse serum was
obtained from NIH wild type mice by cardiac puncture,
and spun for 10 minutes at 6000 g. Serum was kept at 4°C
until use. Mouse brain was homogenized in homogeniza-
tion buffer (137 mM NaCl, 20 mM Tris-HCl pH 7.4, 1%
NonidetP-40, 10% glycerol and proteinase inhibitors
(Roche, Indianapolis, IN)), spun for 20 minutes at 2000 g
and supernatants stored at -80°C until use. To produce
cell culture supernatants for bioassays, McA-RH7777 rat
hepatoma cells were seeded at 105 cells/well in 12-well
plates in serum containing medium, washed with phos-
phate-buffered saline (PBS) for 16 h and incubated with
serum free DMEM for 24 h.
TGF-β bioassay
MFB-F11 cells were seeded at 1 to 4 × 104 cells/well in 96-
well flat-bottom tissue culture plates (BD Falcon, San Jose,
CA). After overnight incubation, cells were washed twice
with PBS and incubated in 50 µl serum-free DMEM sup-
plemented with penicillin/streptomycin (DMEM/P/S) for
2 h before recombinant proteins diluted in DMEM/P/S or
test samples were added in 50 µl volume. In some experi-
ments B27 supplement (Invitrogen, Carlsbad, CA) was
added to serum-free media. Conditioned medium from
cells, mouse brain extract (diluted 1:50) or mouse serum
(diluted 1:100) was added directly (not activated (NA)
condition) or was activated by adding 2.5 µl 6 M HCl to
50 µl sample at room temperature for 10 min followed by
neutralization to pH 7.4 with 6 M NaOH (acid activated
(AA) condition). In some experiments, TGF-β bioactivity
was neutralized before addition to reporter cells by incu-
bating samples with 10 µg/ml of a neutralizing antibody
(clone 1D11, R&D Systems, Minneapolis, MN) for 1 h at
room temperature. 10 µl aliquots of the culture superna-
tants were collected after 24 and 48 h incubation with
MFB-F11 cells. SEAP activity was measured using Great
EscAPe SEAP Reporter system 3 (BD Biosciences, San Jose,
CA) according to the manufacturer's instructions with a
Lmax plate photometer (Molecular Devices, Sunnyvale,
CA). Luciferase activity was detected using the Luciferase
assay system from Promega (Madison, WI) and measured
with a Lumat LB 9507 tube luminometer (EG&G
Berthold).
TGF-β co-culture bioassay
MFB-F11 cells were seeded at 4 × 104 cells/well (Invitro-
gen, Carlsbad, CA) in 96-well flat-bottom tissue culture
plates and allowed to attach for 5 – 12 h. Test cells (McA-
7777RH or B103) were seeded on top at the same density
in DMEM supplemented with 10 % FBS and allowed to
attach for another 4 – 5 h. Wells were washed twice with
PBS and incubated with 100 µl serum free DMEM. SEAP
activity was measured in 10 µl supernatant 24 h later.
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